EQT Life Sciences logo

EQT Life Sciences

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

EQT Life Science develops novel medications, devices, and tools to address people's health concerns.

Investor Profile

EQT Life Sciences has made 177 investments, with 12 in the past 12 months and 37% as lead.

Stage Focus

  • Series B (31%)
  • Series A (30%)
  • Series C (13%)
  • Series Unknown (11%)
  • Series D (6%)
  • Post Ipo Equity (3%)
  • Series E (2%)
  • Debt Financing (2%)
  • Series F (1%)
  • Seed (1%)

Country Focus

  • United States (30%)
  • The Netherlands (21%)
  • Germany (9%)
  • Switzerland (9%)
  • Belgium (7%)
  • France (6%)
  • Ireland (6%)
  • United Kingdom (4%)
  • Spain (2%)
  • Finland (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Health Diagnostics
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EQT Life Sciences frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 9
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 17
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 13
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 16
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 11
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 18
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 21
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 10
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 10
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 10

Which angels does EQT Life Sciences often collaborate with?

KC
North America, United States
Shared Deals: 1
RS
Europe, Southern Finland, Finland, Helsinki
Shared Deals: 1
FC
North America, Florida, United States, Boca Raton
Shared Deals: 1
LF
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Dave Marver
North America, Washington, United States, Seattle
Shared Deals: 1
JB
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Shared Deals: 1
GC
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
RO
North America, Iowa, United States, Des Moines
Shared Deals: 1
KD
Europe, Vaud, Switzerland
Shared Deals: 1

What are some of recent deals done by EQT Life Sciences?

Perfuze

Newcastle, Galway, Ireland

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

Health CareManufacturingMedicalMedical Device
Series UnknownMar 13, 2025
Amount Raised: $23,936,512
Atalanta Therapeutics

Boston, Massachusetts, United States

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

BiotechnologyHealth CareLife Science
Series BJan 28, 2025
Amount Raised: $97,000,000
XyloCor Therapeutics

King Of Prussia, Pennsylvania, United States

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2025
Amount Raised: $67,500,000
Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical
Series BDec 11, 2024
Amount Raised: $30,567,953
Tenpoint Therapeutics

Camborne, Cornwall, United Kingdom

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

BiotechnologyProduct Research
Series UnknownDec 11, 2024
NUA Surgical

Galway, Galway, Ireland

NUA Surgical develops a specialised surgical retractor to make C-Sections a safer and superior surgery.

Cosmetic SurgeryHealth CareMedical Device
Series ADec 6, 2024
Amount Raised: $6,874,153
ATB Therapeutics

Aye, Luxembourg, Belgium

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

BiotechnologyHealth CareTherapeutics
Series ANov 18, 2024
Amount Raised: $57,210,541
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Sequana Medical

Zürich, Zurich, Switzerland

Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo DebtSep 30, 2024
Amount Raised: $3,396,671
PanTera

Mol, Antwerpen, Belgium

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

Health CareManufacturingPharmaceutical
Series ASep 11, 2024
Amount Raised: $110,323,384